
Some supplements billed as ‘smart drugs’ may contain unapproved drugs in potentially dangerous combinations and doses, according to a new …

Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …

The FDA has issued a warning to Massachusetts-based CBD company Curaleaf over the firm’s use of unsubstantiated claims about the …

The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the quality of generics has been …

The overall number of warning letters being sent out by the FDA has dropped under President Donald Trump, according to …

China’s National Health Commission (NHC) has said it will monitor the country’s drugs market more closely in order to ensure …

FDA Commissioner Scott Gottlieb has said that the agency hopes to recruit 50 additional clinical reviewers for the group that …

The FDA approved a record 971 generic drugs in the 2018 fiscal year, giving the go-ahead to 110 generics in …

Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after …

Tanzania has become the first country in Africa to achieve a well-functioning regulatory system for medical products, according to the …

The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …

The Chinese government has fired a senior provincial official and is probing a former senior drug regulator in response to …

The pharmaceutical sector is one of the most tightly regulated industries, and most of the rules that govern the daily …

Johnson & Johnson (NYSE: JNJ) said the US Food and Drug Administration (FDA) has granted Priority Review for its New …
Bristol-Myers Squibb (NYSE: BMY) said the Scottish Medicines Consortium (SMC) has recommended cancer immunotherapy Opdivo (nivolumab) to treat advanced squamous …